Study protocol: Randomized controlled trial of web-based decision support tools for high-risk women and healthcare providers to increase breast cancer chemoprevention

BACKGROUND: Chemoprevention using selective estrogen receptor modulators and aromatase inhibitors has been shown to reduce invasive breast cancer incidence in high-risk women. Despite this evidence, few high-risk women who are eligible for chemoprevention utilize it as a risk-reducing strategy. Reas...

Descripción completa

Detalles Bibliográficos
Autores principales: Crew, Katherine D., Silverman, Thomas B., Vanegas, Alejandro, Trivedi, Meghna S., Dimond, Jill, Mata, Jennie, Sin, Margaret, Jones, Tarsha, Terry, Mary Beth, Tsai, Wei-Yann, Kukafka, Rita
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6722284/
https://www.ncbi.nlm.nih.gov/pubmed/31497674
http://dx.doi.org/10.1016/j.conctc.2019.100433

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6722284/
https://www.ncbi.nlm.nih.gov/pubmed/31497674
http://dx.doi.org/10.1016/j.conctc.2019.100433

Ejemplares similares